Medical Research

Number of patients eligible for genome-driven oncology therapy is increasing, but the percentage who reportedly benefit from the therapy remains at less than 5% Advances in precision medicine in oncology (precision oncology) are fueling...

Dear Reader, This is a survey to better understand the drivers for AI in Digital Pathology and what you consider to be the key enablers/blockers to adoption. We have created a short list of questions and the survey will not take more than...

Aiforia announced today the release of its new product, the CE-IVD marked Aiforia® Clinical, as well as the award of €2.2 million in funding from the EU’s Horizon 2020 program. The EU grant was awarded to support Aiforia’s ongoing...

Aiforia announced the release of Velocity, the latest software release of tools, features and a new product, built upon the current scalable cloud platform, that allow medical and scientific experts to speed-up and simplify image analysis,...

REGISTER NOW Imagine an APP for nuclei segmentation that is reliable and can be used by anyone in your lab. Recent advances in deep learning and artificial intelligence have enabled Visiopharm to develop novel tools for nuclei...

The Danish-based leader in augmented pathology solutions Visiopharm has secured a grant worth £250,000 from UK Research and Innovation to test its innovative solutions in partnership with the NHS. The grant, offered by the UK Government’s...